Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Harvard Business School

Last Updated: December 6, 2021

DrugPatentWatch Database Preview

Patent: 6,994,840

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 6,994,840
Title:Kit for radiolabeling ligands with yttrium-90
Abstract: Methods and kits for radiolabeling proteins, peptides and ligands with radiolytic isotopes, particularly yttrium-90, are disclosed, whereby sufficient purity, specific activity and binding affinity are achieved such that the radiolabeled protein may be directly administered to a patient without further column purification. Such kits and methods will be particularly useful in bringing radioimmunotherapy to the hospital and outpatient setting for the treatment of cancer.
Inventor(s): Chinn; Paul (Carlsbad, CA)
Assignee: Biogen IDEC Inc. (Cambridge, MA)
Application Number:09/628,186
Patent Claims:see list of patent claims

Details for Patent 6,994,840

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Acrotech Biopharma Llc ZEVALIN ibritumomab tiuxetan Injection 125019 2002-02-19 ⤷  Free Forever Trial 2019-03-01
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.